Changes in Mortality Involving Extended-Release and Long-Acting Opioids After Implementation of a Risk Evaluation and Mitigation Strategy

Ítems similars

• Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse Outcomes
  per: Thakral, Manu, et al.
  Publicat: (2018)
• Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States
  per: Young, Jessica C, et al.
  Publicat: (2019)
• Incidence of Opioid Overdose Among Patients Using ER/LA Opioid Analgesics Before and After Implementation of the Class-Wide Opioid Risk Evaluation and Mitigation Strategy
  per: Esposito, Daina B, et al.
  Publicat: (2020)
• ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes
  per: Cepeda, M. Soledad, et al.
  Publicat: (2017)
• The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy
  per: Gudin, Jeffrey A
  Publicat: (2012)